Get the Stockscreener App
7.00
0.57%
0.04
Rezolute Inc stock is traded at $7.00, with a volume of 1.13M.
It is up +0.57% in the last 24 hours and up +30.35% over the past month.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
See More
Previous Close:
$6.96
Open:
$7.01
24h Volume:
1.13M
Relative Volume:
1.13
Market Cap:
$608.97M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-5.5118
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
+7.69%
1M Performance:
+30.35%
6M Performance:
+54.53%
1Y Performance:
+64.71%
1-Day Range:
$6.8909
$7.15
1-Week Range:
$6.23
$7.15
52-Week Range:
$2.215
$7.15
Rezolute Inc Stock (RZLT) Company Profile
Name
Rezolute Inc
Sector
Industry
Phone
650-206-4507
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Compare RZLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
7.00 | 569.82M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | Wedbush | Outperform |
| Aug-27-24 | Initiated | Guggenheim | Buy |
| Jul-17-24 | Initiated | BTIG Research | Buy |
| Jun-04-24 | Initiated | Craig Hallum | Buy |
| Apr-09-24 | Initiated | Maxim Group | Buy |
| Aug-02-22 | Resumed | Canaccord Genuity | Buy |
| Jun-15-22 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-08-21 | Initiated | ROTH Capital | Buy |
| May-27-21 | Initiated | Oppenheimer | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
View All
Rezolute Inc Stock (RZLT) Latest News
Rezolute Inc. Recovery Gathers Momentum on Chart SignalsBuy Signal & Fast Moving Trade Plans - thegnnews.com
Candlestick Signal Suggests Reversal in Rezolute Inc.2025 Key Lessons & Safe Investment Capital Preservation Plans - Newser
Is it too late to sell Rezolute Inc.Market Rally & Long-Term Growth Stock Strategies - Newser
Rezolute appoints Sunil Karnawat as chief commercial officer - Investing.com
Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer - The Globe and Mail
Four-Time Rare Disease Drug Launch Expert Joins Rezolute as CCO to Spearhead Phase 3 Treatment - Stock Titan
Rezolute Appoints New Chief Commercial Officer - TipRanks
Rezolute Inc. stock outlook for YEARChart Signals & AI Optimized Trading Strategy Guides - Newser
Visualizing Rezolute Inc. stock with heatmapsPrice Action & Reliable Volume Spike Trade Alerts - Newser
Should you hold or exit Rezolute Inc. now2025 Short Interest & Accurate Buy Signal Notifications - Newser
Visual analytics tools that track Rezolute Inc. performance2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
Can Rezolute Inc. rally from current levels2025 Valuation Update & High Yield Stock Recommendations - Newser
Analyzing net buyer seller activity in Rezolute Inc.Trade Exit Summary & Trade Opportunity Analysis - Newser
Why Rezolute Inc. is moving todayGlobal Markets & Free High Return Stock Watch Alerts - Newser
Measuring Rezolute Inc.’s beta against major indices2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Rezolute Inc. Crosses 200 Day MA — Signal or NoiseMarket Activity Recap & Low Risk High Win Rate Picks - newsyoung.net
Advanced analytics toolkit walkthrough for Rezolute Inc.July 2025 Intraday Action & Daily Volume Surge Trade Alerts - Newser
What MACD and RSI say about Rezolute Inc.July 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Is Rezolute Inc. still worth holding after the dipJuly 2025 Volume & Daily Growth Stock Tips - Newser
Real time pattern detection on Rezolute Inc. stockJuly 2025 Closing Moves & High Yield Stock Recommendations - Newser
Tools to monitor Rezolute Inc. recovery probability2025 Stock Rankings & Low Drawdown Momentum Ideas - Newser
Is Rezolute Inc. Forming a Consolidation BaseWeekly Profit Recap & Risk Controlled Daily Plans - metal.it
Will Rezolute Inc. price bounce be sustainableJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Will breakout in Rezolute Inc. lead to full recoveryJuly 2025 Opening Moves & Community Driven Trade Alerts - Newser
Signal strength of Rezolute Inc. stock in tech scannersAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
How to monitor Rezolute Inc. with trend dashboardsQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
XTX Topco Ltd Acquires Shares of 32,599 Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Using economic indicators to assess Rezolute Inc. potentialDividend Hike & Stepwise Swing Trade Plans - Newser
Will Rezolute Inc. benefit from macro trendsJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser
Rezolute Inc Stock (RZLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rezolute Inc Stock (RZLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
| Elam Nevan C | CEO |
Mar 27 '25 |
Buy |
2.85 |
12,302 |
34,999 |
224,119 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.89 |
10,000 |
28,900 |
237,900 |
| Evans Daron | CFO |
Mar 26 '25 |
Buy |
2.88 |
10,000 |
28,800 |
23,000 |
| Hogenhuis Wladimir | Director |
Feb 18 '25 |
Buy |
4.70 |
10,000 |
47,000 |
77,267 |
| Evans Daron | CFO |
Dec 18 '24 |
Buy |
4.29 |
10,000 |
42,900 |
150,900 |
| Evans Daron | CFO |
Dec 12 '24 |
Buy |
4.60 |
9,000 |
41,400 |
140,900 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):